Isomura et al. [14] investigated the role of genetic polymorphism of CYP2C19 in a total of 114 cell lines of five gastroenterological cancers and found among the 114 cell lines, biliary tract cancer was suggested to be most strongly associated with poor metabolizers of CYP2C19. This evidence concerns the gene CYP2C19 and biliary tract neoplasm.